Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Telescope Innovations Corp ( (TSE:TELI) ) is now available.
Telescope Innovations Corp has announced that the Korean Pharmaceutical and Biopharmaceutical Manufacturers Association (KPBMA) has purchased its Self-Driving Lab (SDL) platform for installation at a new R&D facility in Seoul. This marks the first deployment of an SDL in Korea, aiming to accelerate pharmaceutical development through AI-driven experimentation. The partnership supports Korea’s shift towards automated and digital R&D, positioning Telescope at the forefront of this transformation. The SDL’s ability to automate and optimize experiments continuously offers significant potential to reduce development timelines and enhance R&D efficiency, with broader applicability across various industries.
More about Telescope Innovations Corp
Telescope Innovations is a chemical technology company that develops scalable manufacturing processes and tools for the pharmaceutical and chemical industries. The company specializes in flexible robotic platforms and artificial intelligence software to enhance experimental throughput, efficiency, and data quality.
Average Trading Volume: 72,915
Technical Sentiment Signal: Buy
Current Market Cap: C$20.94M
For a thorough assessment of TELI stock, go to TipRanks’ Stock Analysis page.